Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center Prospective Cohort Study on the Anti-HPA Antibodies Caused Neonatal Alloimmune Thrombocytopenia in Chinese Pregnant Women

NCT02934906 is registered in ClinicalTrials.gov with Xinqiao Hospital of Chongqing as lead sponsor.

NCT NCT02934906
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02934906 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center Prospective Cohort Study on the Anti-HPA Antibodies Caused Neonatal Alloimmune Thrombocytopenia in Chinese Pregnant Women
Lead sponsor
Xinqiao Hospital of Chongqing
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2017
Completion date
Not reported
Enrollment
55,497 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

neonatal alloimmune thrombocytopenia